Regeneron CEO on 23andMe & $275m in Margaritaville 6/11/25
Squawk Pod
00:00
Genetic Data and Controversy
This chapter explores the significance of collecting genetic data to enhance understanding of health outcomes while hinting at an exclusive interview on the topic. It also raises concerns about the sale of 23andMe to Regeneron, delving into the political implications and privacy issues surrounding the deal.
Transcript
Play full episode
